Trial intelligence / Profile preview

Botox vs Genicular Pulsed RF for Knee Osteoarthritis

NCT03891680Completed

Sponsor
Assiut University
Start
Oct 2019
Primary completion
Mar 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised trial of botulinum toxin type A in osteoarthritis (OA) (2 arms), sponsored by Assiut University. Primary endpoint: Pain visual analog scale at 6 months. Started Oct 2019; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03891680.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03891680.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call